Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Cross-referencing NIH grants against published research and clinical trials to identify funding-evidence gaps for Tongue Squamous Cell Carcinoma. Strongest funded area: Basic Science. Largest gap: Biomarker / Diagnostics.
Clinical ResearchTrials Active, No NIH Grants
7 clinical trials registered but no NIH-funded clinical or translational research grants found for tongue squamous cell carcinoma. Trials may be industry-sponsored or funded through non-NIH sources.
Biomarker / DiagnosticsPublished, Not NIH-Funded
9 publications in Diagnostic / Biomarker but no NIH-funded grants found in Biomarker / Diagnostics for tongue squamous cell carcinoma. Existing research activity suggests this may be a viable area for grant applications.
Translational / Drug DevelopmentPublished, Not NIH-Funded
5 publications in Gene Therapy / Novel Therapeutics but no NIH-funded grants found in Translational / Drug Development for tongue squamous cell carcinoma. Existing research activity suggests this may be a viable area for grant applications.
Adjacent Research(2 grants)
These grants mention Tongue Squamous Cell Carcinoma as part of broader research but are not primarily focused on this disease. They are not included in the funding totals above.
Other(2)
OtherR01Active
Targeted inhibition of eIF5Ahpu suppresses tumor growth and M2-like TAM polarization in oral cancer
Le, Anh·UNIVERSITY OF PENNSYLVANIA·PHILADELPHIA, PA
